Chronic kidney disease and the gut microbiome

被引:196
|
作者
Hobby, Gerren P. [1 ]
Karaduta, Oleg [3 ]
Dusio, Giuseppina F. [1 ]
Singh, Manisha [1 ,2 ]
Zybailov, Boris L. [3 ]
Arthur, John M. [1 ,2 ]
机构
[1] Univ Arkansas Med Sci, Div Nephrol, Little Rock, AR 72211 USA
[2] Cent Arkansas Vet Hlth Syst, Little Rock, AR USA
[3] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72211 USA
关键词
chronic kidney disease; disease progression; gastrointestinal tract; indoxyl sulfate; metaproteomics; microbiome; P-CRESYL SULFATE; CHAIN FATTY-ACIDS; INDOXYL SULFATE; BIFIDOBACTERIUM; EPIDEMIOLOGY; ASSOCIATION; METABOLITES; DIVERSITY; FAILURE; SOLUTES;
D O I
10.1152/ajprenal.00298.2018
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The gut microbiome is composed of a diverse population of bacteria that have beneficial and adverse effects on human health. The microbiome has recently gained attention and is increasingly noted to play a significant role in health and a number of disease states. Increasing urea concentration during chronic kidney disease (CKD) leads to alterations in the intestinal flora that can increase production of gut-derived toxins and alter the intestinal epithelial harrier. These changes can lead to an acceleration of the process of kidney injury. A number of strategies have been proposed to interrupt this pathway of injury in CKD. The purpose of this review is to summarize the role of the gut microbiome in CKD, tools used to study this microbial population, and attempts to alter its composition for therapeutic purposes.
引用
收藏
页码:F1211 / F1217
页数:7
相关论文
共 50 条
  • [41] Chronic kidney disease and gut microbiota
    Khiabani, Siamak Amini
    Asgharzadeh, Mohammad
    Kafil, Hossein Samadi
    HELIYON, 2023, 9 (08)
  • [42] Gut microbiota in chronic kidney disease
    Cigarran Guldris, Secundino
    Gonzalez Parra, Emilio
    Cases Amenos, Aleix
    NEFROLOGIA, 2017, 37 (01): : 9 - 19
  • [43] Changes in the Gut Microbiome in Chronic Obstructive Pulmonary Disease
    Rehman, S. F.
    Bowerman, K. L.
    Lachner, N.
    Budden, K. F.
    Kim, R.
    Wood, D. L.
    Gellatly, S. L.
    Wark, P. A.
    Hugenholtz, P.
    Hansbro, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [44] Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist?
    Vasylyeva, Tetyana L.
    Singh, Ruchi
    FRONTIERS IN MICROBIOLOGY, 2016, 7
  • [45] Gut microbiome and kidney stone disease: not just an Oxalobacter story
    Ticinesi, Andrea
    Nouvenne, Antonio
    Meschi, Tiziana
    KIDNEY INTERNATIONAL, 2019, 96 (01) : 25 - 27
  • [46] The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease
    Tao Yang
    Elaine M. Richards
    Carl J. Pepine
    Mohan K. Raizada
    Nature Reviews Nephrology, 2018, 14 : 442 - 456
  • [47] Indoxyl sulfate and altered gut microbiome heightened the risk of chronic kidney disease in obstructive sleep apnea
    Mohit
    Chand, Pooran
    Verma, Sheetal
    SLEEP, 2025,
  • [48] Sugar types, genetic predictors of the gut microbiome, and the risk of chronic kidney disease: a prospective cohort study
    Zheng, Gang
    Zhang, Yixiao
    Ou, Fengrong
    Chang, Qing
    Ji, Chao
    Yang, Honghao
    Chen, Liangkai
    Xia, Yang
    Zhao, Yuhong
    FOOD & FUNCTION, 2024, 15 (09) : 4925 - 4935
  • [49] Vascular Calcification and the Gut and Blood Microbiome in Chronic Kidney Disease Patients on Peritoneal Dialysis: A Pilot Study
    Merino-Ribas, Ana
    Araujo, Ricardo
    Pereira, Luciano
    Campos, Joana
    Barreiros, Luisa
    Segundo, Marcela A.
    Silva, Nadia
    Costa, Carolina F. F. A.
    Quelhas-Santos, Janete
    Trindade, Fabio
    Falcao-Pires, Ines
    Alencastre, Ines
    Dumitrescu, Ioana Bancu
    Sampaio-Maia, Benedita
    BIOMOLECULES, 2022, 12 (07)
  • [50] Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome
    Lecamwasam, Ashani
    Ekinci, Elif I.
    Saffery, Richard
    Dwyer, Karen M.
    BIOMEDICINES, 2020, 8 (09)